Argenx
ARGX
#625
Rank
S$42.34 B
Marketcap
$698.60
Share price
1.38%
Change (1 day)
-2.16%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$0.69 B

According to Argenx 's latest financial reports the company's total liabilities are S$0.69 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2021 to 2020)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$0.42 B0.83%
2021-12-31S$0.42 B-56.43%
2020-12-31S$0.97 B50.75%
2019-12-31S$0.64 B807.43%
2018-12-31S$71.51 M42.99%
2017-12-31S$50.01 M-26.32%
2016-12-31S$67.88 M362.58%
2015-12-31S$14.67 M-10.97%
2014-12-31S$16.48 M106.13%
2013-12-31S$7.99 M-21.24%
2012-12-31S$10.15 M49.35%
2011-12-31S$6.79 M95.99%
2010-12-31S$3.46 M